CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
000930 Cofco Biotechnology
- 5.47
- -0.01-0.18%
Market Closed Apr 30 15:00 CST
10.17BMarket Cap248.64P/E (TTM)
5.52High5.45Low103.86KlotVolume5.49Open5.48Pre Close56.97MTurnover0.56%Turnover Ratio390.71P/E (Static)1.86BShares6.6452wk High0.96P/B10.15BFloat Cap4.4252wk Low6.03Limit Up1.86BShs Float28.28Historical High4.93Limit Down1.28%Amplitude0.80Historical Low--Dividend TTM5.49Avg Price51.25KlotAsk--Div YieldTTM100Lot Size48.19KlotBid
Cofco Biotechnology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -7.31%4.39B | -1.60%20.05B | 2.74%15.12B | 6.45%9.91B | 4.63%4.73B | 2.31%20.38B | -1.18%14.72B | -12.25%9.31B | -15.95%4.52B | -15.46%19.92B |
| Operating revenue | -7.31%4.39B | -1.60%20.05B | 2.74%15.12B | 6.45%9.91B | 4.63%4.73B | 2.31%20.38B | -1.18%14.72B | -12.25%9.31B | -15.95%4.52B | -15.46%19.92B |
| Other operating revenue | ---- | -11.68%277.71M | ---- | -13.95%141.83M | ---- | 5.02%314.46M | ---- | 52.87%164.82M | ---- | -8.57%299.42M |
| Total operating cost | -6.60%4.31B | -3.72%19.63B | 1.22%14.84B | 3.69%9.69B | 2.21%4.61B | 9.06%20.39B | 6.37%14.66B | -3.60%9.35B | -9.51%4.51B | -15.45%18.7B |
| Operating cost | -8.10%4.03B | -3.98%18.49B | 0.87%14B | 3.56%9.15B | 2.92%4.39B | 9.00%19.26B | 6.11%13.88B | -3.91%8.84B | -9.93%4.26B | -15.63%17.67B |
| Operating tax surcharges | 4.87%22.45M | 9.05%97.18M | 10.30%72.02M | 8.84%46.63M | 9.19%21.41M | 9.24%89.11M | 3.87%65.29M | -6.68%42.84M | 5.56%19.61M | -12.05%81.58M |
| Operating expense | -4.62%46.06M | -4.88%193.54M | -3.17%140.25M | 1.40%94.84M | 9.27%48.29M | 2.95%203.47M | 2.56%144.85M | -0.66%93.53M | -13.82%44.19M | -10.32%197.65M |
| Administration expense | 11.28%125.11M | 8.00%632.82M | 12.13%443.19M | 7.85%278.34M | -10.23%112.42M | -3.87%585.92M | -3.81%395.26M | -3.53%258.07M | -4.74%125.23M | 2.56%609.52M |
| Financial expense | 160.82%26.97M | -1.95%89.09M | 21.68%78.44M | -9.87%39.94M | -69.02%10.34M | 953.70%90.85M | 900.44%64.46M | 538.22%44.32M | 186.54%33.38M | -94.13%8.62M |
| -Interest expense (Financial expense) | -0.71%23.23M | -7.02%104.86M | -8.53%82.78M | -12.40%53.57M | -20.27%23.39M | 29.45%112.78M | 29.07%90.5M | 34.07%61.15M | 89.28%29.34M | -44.78%87.12M |
| -Interest Income (Financial expense) | 43.53%-1.43M | -26.86%-20.58M | -20.10%-12.22M | 40.44%-4.07M | -13.90%-2.52M | 0.10%-16.22M | 11.95%-10.18M | 23.57%-6.83M | 65.81%-2.22M | -5.10%-16.24M |
| Research and development | 76.09%53.91M | -22.05%128.83M | -5.59%106.73M | 12.74%82.9M | 19.52%30.61M | 24.40%165.28M | 16.50%113.05M | -16.56%73.53M | -34.38%25.61M | 11.39%132.86M |
| Credit Impairment Loss | -105.78%-185.76K | -5,618.38%-38.52M | 267.33%1.35M | 266.79%2.33M | 9,844.13%3.21M | 74.85%-673.65K | -187.61%-809.67K | -248.59%-1.4M | 113.01%32.3K | -126.33%-2.68M |
| Asset Impairment Loss | 15.14%-72.66M | 29.32%-419.57M | 27.80%-251.79M | 46.69%-150.25M | ---85.63M | -217.73%-593.58M | -511.82%-348.75M | -394.44%-281.84M | ---- | 3.97%-186.82M |
| Other net revenue | 58.30%-33.56M | 37.44%-350.94M | 37.97%-191.68M | 60.61%-99.95M | -687.98%-80.47M | -535.13%-560.97M | -293.37%-309.01M | -290.94%-253.76M | -74.96%13.69M | 280.19%128.92M |
| Fair value change income | 14,763.03%4.45M | 75.30%-8.13M | -96.96%-35.83M | 101.64%293.31K | 99.65%-30.35K | -2,022.48%-32.93M | -109.52%-18.19M | -275.02%-17.93M | 5.71%-8.56M | -7.77%1.71M |
| Invest income | 470.52%32.1M | 123.40%50.38M | 202.17%48.75M | 364.96%27.01M | -257.88%-8.66M | 477.40%22.55M | 828.70%16.13M | 154.54%5.81M | 159.40%5.49M | -114.92%-5.98M |
| -Including: Investment income associates | 339.86%149.67K | 107.06%202.1K | 122.38%627.61K | 118.64%528.01K | 101.00%34.03K | 58.88%-2.86M | 19.05%-2.8M | 64.44%-2.83M | 37.47%-3.4M | -87.60%-6.96M |
| Asset deal income | --0 | -112.75%-147.95K | -101.58%-85.24K | -100.97%-81.66K | -101.06%-81.66K | 100.80%1.16M | 102.64%5.4M | 104.58%8.38M | 104.44%7.68M | 28.24%-145.82M |
| Other revenue | -74.45%2.74M | 53.05%65.05M | 23.38%45.92M | -37.54%20.75M | 18.52%10.72M | -90.93%42.5M | -91.37%37.22M | -91.43%33.22M | -96.33%9.05M | 70.91%468.5M |
| Operating profit | 11.76%46.16M | 112.49%71.51M | 137.55%93.22M | 140.34%117.8M | 61.89%41.31M | -142.39%-572.38M | -119.48%-248.27M | -127.96%-291.98M | -94.34%25.51M | -1.79%1.35B |
| Add:Non operating Income | 24.79%12.41M | 60.44%64.43M | 566.90%33.8M | 458.45%13.9M | 756.66%9.95M | 10.24%40.16M | -79.25%5.07M | -74.64%2.49M | -85.23%1.16M | -23.83%36.43M |
| Less:Non operating expense | 21.02%311.52K | -36.63%6.54M | -6.23%4.71M | -89.68%746.22K | -65.63%257.41K | -61.34%10.32M | -67.18%5.03M | 18.34%7.23M | 106.03%748.86K | -41.02%26.7M |
| Total profit | 14.25%58.26M | 123.85%129.4M | 149.27%122.31M | 144.13%130.95M | 96.68%50.99M | -139.90%-542.54M | -119.34%-248.22M | -128.31%-296.73M | -94.34%25.93M | -1.27%1.36B |
| Less:Income tax cost | -37.48%16.48M | 13.49%83.7M | 3.57%100.57M | 13.80%64.06M | 18.12%26.35M | -75.36%73.75M | -67.18%97.1M | -76.82%56.29M | -79.03%22.31M | 20.74%299.28M |
| Net profit | 69.57%41.78M | 107.42%45.7M | 106.29%21.73M | 118.95%66.89M | 581.20%24.64M | -158.11%-616.29M | -134.97%-345.33M | -143.84%-353.02M | -98.97%3.62M | -6.10%1.06B |
| Net profit from continuing operation | 69.57%41.78M | 107.42%45.7M | 106.29%21.73M | 118.95%66.89M | 581.20%24.64M | -158.11%-616.29M | -134.98%-345.33M | -143.84%-353.02M | -98.97%3.62M | -6.10%1.06B |
| Less:Minority Profit | 727.14%1.25M | 240.29%20.57M | 197.32%12.13M | 130.40%5.4M | -109.21%-199.65K | -804.17%-14.66M | -156.95%-12.46M | -191.75%-17.78M | -18.06%2.17M | 2,377.88%2.08M |
| Net profit of parent company owners | 63.17%40.53M | 104.18%25.13M | 102.89%9.6M | 118.34%61.48M | 1,613.02%24.84M | -156.84%-601.63M | -134.47%-332.87M | -142.66%-335.24M | -99.58%1.45M | -6.29%1.06B |
| Earning per share | ||||||||||
| Basic earning per share | 62.69%0.0218 | 104.13%0.0135 | 102.86%0.0052 | 118.06%0.0331 | 1,575.00%0.0134 | -157.32%-0.3267 | -134.99%-0.1818 | -143.29%-0.1833 | -99.58%0.0008 | -6.97%0.57 |
| Diluted earning per share | 62.69%0.0218 | 104.13%0.0135 | 102.91%0.0052 | 118.06%0.0331 | 1,575.00%0.0134 | -157.33%-0.3267 | -134.45%-0.179 | -143.29%-0.1833 | -99.57%0.0008 | -6.71%0.5699 |
| Other composite income | 117.07%8.99M | 66.86%45.44M | 801.35%42.7M | -371.64%-54.53M | -354.30%-52.68M | -64.22%27.23M | -116.32%-6.09M | 53.94%20.08M | 4.59%-11.6M | 326.03%76.11M |
| Other composite income of parent company owners | 117.07%8.99M | 66.86%45.44M | 801.35%42.7M | -371.64%-54.53M | -354.30%-52.68M | -64.22%27.23M | -116.32%-6.09M | 53.94%20.08M | 4.59%-11.6M | 326.03%76.11M |
| Total composite income | 281.08%50.78M | 115.47%91.14M | 118.34%64.43M | 103.71%12.35M | -251.44%-28.04M | -151.82%-589.06M | -134.29%-351.42M | -140.69%-332.94M | -102.35%-7.98M | 3.73%1.14B |
| Total composite income of parent company owners | 277.88%49.52M | 112.29%70.57M | 115.43%52.3M | 102.20%6.95M | -174.40%-27.84M | -150.62%-574.4M | -133.80%-338.96M | -139.45%-315.17M | -103.01%-10.15M | 3.53%1.13B |
| Total composite income of minority owners | 727.14%1.25M | 240.29%20.57M | 197.32%12.13M | 130.40%5.4M | -109.21%-199.65K | -804.17%-14.66M | -156.95%-12.46M | -191.75%-17.78M | -18.06%2.17M | 2,377.88%2.08M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.